Evidence map›Paper›PMID 8077384›Full record

ArticleJournal of clinical microbiology1994

Detection of cytomegalovirus DNA in sera of liver transplant recipients.

R Patel, T F Smith, M Espy, R H Wiesner, R A Krom, D Portela, C V Paya

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00001477 (Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00001477 completednot on this mapstarted 1995, after this paper: background citation

Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran1995 to 2000Enrolled300ConditionsCommunicable Diseases, Opportunistic Infections
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Detection of human cytomegalovirus DNA in various blood components after liver transplantation.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2014
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Evaluation of PCR primers for cytomegalovirus detection.Journal of clinical microbiology · 1999
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Infections in solid-organ transplant recipients.Clinical microbiology reviews · 1997
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R PatelDivision of Infectious Disease and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
T F Smith
M Espy
R H Wiesner
R A Krom
D Portela
C V Paya
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We prospectively studied the utility of the amplification of cytomegalovirus (CMV) DNA in the sera of liver transplant recipients in order to predict symptomatic CMV infection, thus enabling preemptive therapy with antiviral agents. Serum samples obtained at biweekly intervals from 20 sequential liver transplant recipients for at least 8 weeks following transplantation were tested by the PCR amplification procedure. Results were correlated with blood and urine cultures, histopathological findings from infected organs, and clinical manifestations. Six patients (30%) developed symptomatic CMV infection; in five (83%) of these patients, CMV DNA was detected prior to symptomatic CMV infection, and in one (17%) of these patients, CMV DNA was detected at the time of symptomatic CMV infection. CMV DNA was detected a mean of 13 days (range, 0 to 23 days) prior to the onset of symptomatic CMV infection. In addition, CMV DNA was detected in the sera of four of five patients with asymptomatic viremia and two patients with asymptomatic viruria. Lastly, the PCR was negative for sera from seven patients with no evidence of CMV infection. We found that PCR was able to detect the presence of CMV DNA in the sera of liver transplant recipients at a sensitivity of 92% and a specificity of 100% for CMV infection, while the sensitivity and specificity for symptomatic infection were 100 and 57%, respectively.

Indexed as

Liver TransplantationPolymerase Chain ReactionBase SequenceCytomegalovirusCytomegalovirus InfectionsDNA, ViralGanciclovirMolecular Sequence DataPlasmaPostoperative ComplicationsProspective StudiesSensitivity and SpecificityUrineViremiaDNA, ViralGanciclovir

Identifiers

PMID8077384
PMCPMC264014
OpenAlexW2106008022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.